Innfocus (Miami) reported raising $32.8 million in a Series C funding round. The firm is one of several competing companies Medical Device Daily has dubbed the MIGS-6, in the minimally invasive glaucoma surgical space. The group has been highly active within the past few months, with activity that ranges from clinical trial completions to initial public offerings.
Read More
